Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision v3.5.4 was added to the study record history, superseding the previous v3.5.3. This update records the latest page changes.
    Difference
    0.0%
    Check dated 2026-05-15T02:17:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision history now lists Revision: v3.5.3. The previous entry Revision: v3.5.2 is removed from the history listing.
    Difference
    0.0%
    Check dated 2026-04-30T18:57:48.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page metadata (footer), a technical version change with no impact on study content.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was deleted in the record history.
    Difference
    0.0%
    Check dated 2026-03-18T19:41:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and removes Revision: v3.4.2. This is a minor version update to the history display.
    Difference
    0.0%
    Check dated 2026-03-11T17:39:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new version entry was added showing a recruitment status update to the trial record history.
    Difference
    0.0%
    Check dated 2026-02-25T10:17:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.